ODDB.org: Open Drug Database

Zambon Svizzera SA - Rivasur due volte alla settimana 4,6 mg/24 ore, cerotto transdermico

Swissmedic Registration	68897	Sequence	01
Product name	Rivasur due volte alla settimana 4,6 mg/24 ore	Description	cerotto transdermico
ATC-Classification	N06DA03	ATC-Description	Rivastigmine
Introduction of Sequence	13.02.2024

Composition

I) (cerotto transdermico): rivastigminum 25.92 mg, E 307, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, butylis methacrylatis et methylis methacrylatis polymerisatum, polyisobutylenum, polybutylenum, materiale di supporto: poly(ethylenis terephthalas), polyethylenum, tinta: blu, ad praeparationem pro 10.8 cm², cum liberatione 4.6 mg/24h. II) (cerotto di copertura): acrylates et vinylis acetatis polymerisatum, materiale di supporto: polyesterum, ad praeparationem pro 25.1 cm².

Packungsbestandteile

Label

Galenic Form

cerotto transdermico

Active Agent	Dose
(Cerotto Transdermico): Rivastigminum	25.92 mg

BAG: Active Agent
Rivastigmine

Inactive agents	Dose	additional_information
2-ethylhexylis Acrylatis
Ad Praeparationem	10.8 cm
Blu		tinta
Butylis Methacrylatis
Cum Liberatione	4.6mg / 24h
E 307
Methylis Methacrylatis Polymerisatum
Poly(Ethylenis Terephthalas)		materiale di supporto
Polybutylenum
Polyethylen
Polyisobutylenum
Vinylis Acetatis Polymerisatum

Label

Galenic Form

cerotto transdermico

BAG: Active Agent
Rivastigmine

Inactive agents	Dose	additional_information
(Cerotto di Copertura): Acrylates
Ad Praeparationem	25.1 cm
Polyesterum		materiale di supporto
Vinylis Acetatis Polymerisatum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002	8	32.31	51.55	B	SL	No
003	16	64.62	86.70	B	SL	No

2026	©ywesee GmbH